WARD Home

WARD 24/7 > WARD Home

WARD-Home

Study design

Observational
 

Sample size

80 participants

 

Study sites

Bispebjerg Hospital and the patients’ own homes

 

Inclusion criteria

Adult patients (≥ 18 years) admitted with an acute medical disease and who are scheduled for discharge to their own homes within five days from inclusion. 

 

Study Procedures

Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge. Monitoring will last for a maximum of eight days. 


Primary outcome

Minutes during the measurement period with complete data from the LifeTouch device.


Primary Investigator

Vibeke Eriksen, MD, PhD


NCT link

NCT05223504